SEPTIN9 and neoplasm: A significant difference of SEPT9 methylation levels was further demonstrated between local tumour and systemic tumour burden (M0 vs. M1a) but not between one and multiple metastatic sites (M1a vs. M1b, Tables 2 and 3).